Meadow Brook Investment Advisors LLC Syndax Pharmaceuticals Inc Transaction History
Meadow Brook Investment Advisors LLC
- $111 Billion
- Q3 2024
A detailed history of Meadow Brook Investment Advisors LLC transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Meadow Brook Investment Advisors LLC holds 1,500 shares of SNDX stock, worth $24,135. This represents 0.03% of its overall portfolio holdings.
Number of Shares
1,500
Previous 1,700
11.76%
Holding current value
$24,135
Previous $34.9 Million
17.27%
% of portfolio
0.03%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding SNDX
# of Institutions
227Shares Held
88.3MCall Options Held
1.01MPut Options Held
692K-
Black Rock Inc. New York, NY7.91MShares$127 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ5.84MShares$94 Million9.23% of portfolio
-
Wellington Management Group LLP Boston, MA4.99MShares$80.2 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.89MShares$78.6 Million0.0% of portfolio
-
Eversept Partners, LP New York, NY4.11MShares$66.1 Million6.25% of portfolio
About Syndax Pharmaceuticals Inc
- Ticker SNDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,565,200
- Market Cap $910M
- Description
- Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...